Cove Street Capital LLC trimmed its stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 54.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 160,261 shares of the company's stock after selling 188,906 shares during the period. Viemed Healthcare accounts for 1.5% of Cove Street Capital LLC's portfolio, making the stock its 27th largest position. Cove Street Capital LLC owned 0.41% of Viemed Healthcare worth $1,285,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently made changes to their positions in the stock. Wasatch Advisors LP boosted its stake in Viemed Healthcare by 19.6% in the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company's stock valued at $13,552,000 after acquiring an additional 303,277 shares in the last quarter. Rice Hall James & Associates LLC acquired a new stake in shares of Viemed Healthcare in the 4th quarter worth $2,083,000. First Eagle Investment Management LLC boosted its position in shares of Viemed Healthcare by 196.5% in the 4th quarter. First Eagle Investment Management LLC now owns 328,824 shares of the company's stock worth $2,637,000 after purchasing an additional 217,923 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new position in Viemed Healthcare during the 4th quarter worth $1,549,000. Finally, JPMorgan Chase & Co. increased its position in Viemed Healthcare by 131.4% during the 4th quarter. JPMorgan Chase & Co. now owns 228,652 shares of the company's stock valued at $1,834,000 after buying an additional 129,854 shares in the last quarter. 74.24% of the stock is currently owned by hedge funds and other institutional investors.
Viemed Healthcare Stock Down 1.1 %
NASDAQ VMD traded down $0.08 during trading on Thursday, hitting $6.99. The company's stock had a trading volume of 49,148 shares, compared to its average volume of 135,367. Viemed Healthcare, Inc. has a fifty-two week low of $6.21 and a fifty-two week high of $9.81. The company has a market cap of $276.26 million, a PE ratio of 25.89 and a beta of 1.50. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The business's 50 day simple moving average is $7.76 and its 200-day simple moving average is $8.18.
About Viemed Healthcare
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Articles
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
